Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose.

Am J Obstet Gynecol · 2022 · PMC9008977 · PMID 35430228

Europe PMC DOI

hedged sentence

0.0620

closest p · 1.2× alpha

0.0620

boldest claim

The sentences

did not reach statistical significanceP =.062so close (0.05 < p ≤ 0.1)

A similar trend of antibody waning was observed for the boosted convalescent group, although this did not reach statistical significance ( P =.062), and no change was observed in the convalescent group ( Figure 5 , A).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.